No black box warning on record for Prevduo

As of the latest FDA labeling reviewed, Prevduo (NEOSTIGMINE METHYLSULFATE AND GLYCOPYRROLATE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Prevduo medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Bradycardia : consideration should be given to administration of glycopyrrolate prior to neostigmine (i.e., as separate products) in patients with bradycardia or in patients in whom bradycardia, a known risk of neostigmine methysulfate, may cause hemodynamic instability. ( 5.1 ) • Serious Reactions with Coexisting Conditions : Use with caution in patients with, coronar

No black box warning on record for Prevduo

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Bradycardia : consideration should be given to administration of glycopyrrolate prior to neostigmine (i.e., as separate products) in patients with bradycardia or in patients in whom bradycardia, a known risk of neostigmine methysulfate, may cause hemodynamic instability. ( 5.1 ) • Serious Reactions with Coexisting Conditions : Use with caution in patients with, coronar

Prevduo Black Box Warning

No black box warning on record for Prevduo

Other warnings & precautions

Prevduo Black Box Warning

No black box warning on record for Prevduo

Other warnings & precautions